Jun 24, 2022 · Tori Rodriguez, MA, LPC, AHC, is an Atlanta-based journalist, licensed psychotherapist, and Ayurvedic health coach, creator of the body-positive wellness company Bettie Page Fitness, and author of 2 books – The Little Book of Bettie: Taking a Page from the Queen of Pinups and Bettie Page: The Lost Years.

Nov 15, 2024 · A photobiomodulation therapy device has received approval by the US Food and Drug Administration (FDA) to be marketed for the treatment of nonexudative (dry) age-related macular degeneration (AMD), according to statements from the FDA and the manufacturer.The device allows physicians the opportunity to offer a noninvasive treatment for dry AMD with a low-level laser therapy (LLLT) technology. 1,2

Dec 4, 2024 · The Food and Drug Administration (FDA) has approved a generic latanoprost, a prostaglandin analogue, for the treatment of open-angle glaucoma and ocular hypertension, according to a pharmaceutical manufacturer’s press release.The announcement from Gland Pharma Limited says that the FDA has found the generic latanoprost both bioequivalent and therapeutically equivalent to Xalatan ...

Sep 18, 2024 · Glucagon-like peptide-1 receptor (GLP-1R) agonist therapy used for the treatment of diabetes is significantly associated with a small decrease in intraocular pressure (IOP), according to study results published in the American Journal of Ophthalmology.The therapy is also linked with neuroprotection in neurodegenerative processes, according to the report.

Jul 20, 2023 · Myasthenia gravis (MG) can occur in 2 forms: a generalized myasthenia gravis (GMG) or purely ocular myasthenia gravis (OMG). Ocular myasthenia gravis is characterized by progressive fatigability of skeletal muscle limited to the orbicularis oculi, levator palpebrae superioris, and the extraocular muscles. 1 Up to half of patients diagnosed with MG present with ocular muscle weakness before ...

Oct 28, 2024 · A subgroup analysis exploring the supplement’s ability to limit disease progression risk revealed that patients with early nonexudative AMD were less likely to progress to advanced nonexudative AMD than individuals who did not use the supplement (4.32% vs 7.50%; P <.001).However, using curcuma-based nutritional supplements did not affect exudative AMD development risk.

Nov 11, 2024 · A polygenic risk score (PRS) threshold can identify individuals at high and low risk for developing primary open-angle glaucoma (POAG), according to research published in JAMA Ophthalmology.. Researchers conducted a post hoc analysis of the Ocular Hypertension Treatment Study (OHTS) (ClinicalTrials.gov Identifier: NCT00000125), a multicenter randomized clinical trial of 1636 participants with ...

Nov 10, 2024 · The study analyzed medical records of 940,763 individuals and found that ADHD was more prevalent among people with keratoconus compared with among the whole cohort (0.24% vs 0.16%). 7 The study also shows that people with keratoconus are approximately 1.6 times more likely to be diagnosed with ADHD.

Nov 20, 2023 · Preservative-free sodium hyaluronate (0.4%) eye drops in different dosages effectively alleviates signs and symptoms of dye eye disease (DED) after 1 month of treatment in approximately 50% of patients, according to a study published in Clinical Ophthalmology.. Researchers investigated the effectiveness of the preservative-free sodium hyaluronate drops in a randomized, parallel assignment ...

Oct 20, 2024 · As a result, participants in the high-dose gene therapy arm improved from baseline to week 52 by a mean of 0.337±0.0829 logMAR, which is significant compared with those who received sham therapy (P =.0209).. Notably, 76-week gains reached 0.539±0.1032 logMAR, also substantial in comparison with placebo (P =.0014).Patients with low-dose had 52-week progress of 0.382±0.1244 logMAR (P =.0290 ...